vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Fidelity National Financial, Inc. (FNF). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $544.0M, roughly 1.8× Fidelity National Financial, Inc.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -21.5%, a 29.2% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 10.3%). Over the past eight quarters, Fidelity National Financial, Inc.'s revenue compounded faster (13.7% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

ATR vs FNF — Head-to-Head

Bigger by revenue
ATR
ATR
1.8× larger
ATR
$962.7M
$544.0M
FNF
Growing faster (revenue YoY)
ATR
ATR
+3.2% gap
ATR
13.5%
10.3%
FNF
Higher net margin
ATR
ATR
29.2% more per $
ATR
7.7%
-21.5%
FNF
Faster 2-yr revenue CAGR
FNF
FNF
Annualised
FNF
13.7%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
FNF
FNF
Revenue
$962.7M
$544.0M
Net Profit
$74.3M
$-117.0M
Gross Margin
Operating Margin
11.0%
82.9%
Net Margin
7.7%
-21.5%
Revenue YoY
13.5%
10.3%
Net Profit YoY
-26.4%
-126.0%
EPS (diluted)
$1.13
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
FNF
FNF
Q4 25
$962.7M
$544.0M
Q3 25
$961.1M
$553.0M
Q2 25
$966.0M
$547.0M
Q1 25
$887.3M
$455.0M
Q4 24
$848.1M
$493.0M
Q3 24
$909.3M
$506.0M
Q2 24
$910.1M
$504.0M
Q1 24
$915.4M
$421.0M
Net Profit
ATR
ATR
FNF
FNF
Q4 25
$74.3M
$-117.0M
Q3 25
$127.9M
$358.0M
Q2 25
$111.7M
$278.0M
Q1 25
$78.8M
$83.0M
Q4 24
$100.9M
$450.0M
Q3 24
$100.0M
$266.0M
Q2 24
$90.5M
$306.0M
Q1 24
$83.1M
$248.0M
Operating Margin
ATR
ATR
FNF
FNF
Q4 25
11.0%
82.9%
Q3 25
14.2%
81.9%
Q2 25
14.9%
69.8%
Q1 25
12.8%
24.4%
Q4 24
14.2%
Q3 24
15.2%
61.9%
Q2 24
13.8%
90.9%
Q1 24
12.2%
78.6%
Net Margin
ATR
ATR
FNF
FNF
Q4 25
7.7%
-21.5%
Q3 25
13.3%
64.7%
Q2 25
11.6%
50.8%
Q1 25
8.9%
18.2%
Q4 24
11.9%
91.3%
Q3 24
11.0%
52.6%
Q2 24
9.9%
60.7%
Q1 24
9.1%
58.9%
EPS (diluted)
ATR
ATR
FNF
FNF
Q4 25
$1.13
$-0.44
Q3 25
$1.92
$1.33
Q2 25
$1.67
$1.02
Q1 25
$1.17
$0.30
Q4 24
$1.48
$1.65
Q3 24
$1.48
$0.97
Q2 24
$1.34
$1.12
Q1 24
$1.23
$0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
FNF
FNF
Cash + ST InvestmentsLiquidity on hand
$409.5M
$2.6B
Total DebtLower is stronger
$1.1B
$4.4B
Stockholders' EquityBook value
$2.7B
$7.4B
Total Assets
$5.3B
$109.0B
Debt / EquityLower = less leverage
0.43×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
FNF
FNF
Q4 25
$409.5M
$2.6B
Q3 25
$264.8M
$3.5B
Q2 25
$169.8M
$3.3B
Q1 25
$136.8M
$4.5B
Q4 24
$226.2M
$3.5B
Q3 24
$327.9M
$5.0B
Q2 24
$223.9M
$4.9B
Q1 24
$201.1M
$3.5B
Total Debt
ATR
ATR
FNF
FNF
Q4 25
$1.1B
$4.4B
Q3 25
$546.0M
$4.4B
Q2 25
$535.1M
$4.4B
Q1 25
$561.2M
$4.4B
Q4 24
$688.1M
$4.3B
Q3 24
$822.7M
$4.2B
Q2 24
$681.5M
$4.2B
Q1 24
$680.4M
$3.9B
Stockholders' Equity
ATR
ATR
FNF
FNF
Q4 25
$2.7B
$7.4B
Q3 25
$2.8B
$8.4B
Q2 25
$2.7B
$7.9B
Q1 25
$2.5B
$7.9B
Q4 24
$2.5B
$7.8B
Q3 24
$2.5B
$8.1B
Q2 24
$2.4B
$7.3B
Q1 24
$2.3B
$7.1B
Total Assets
ATR
ATR
FNF
FNF
Q4 25
$5.3B
$109.0B
Q3 25
$5.1B
$106.6B
Q2 25
$4.9B
$102.3B
Q1 25
$4.5B
$98.2B
Q4 24
$4.4B
$95.4B
Q3 24
$4.6B
$94.7B
Q2 24
$4.5B
$88.8B
Q1 24
$4.4B
$84.5B
Debt / Equity
ATR
ATR
FNF
FNF
Q4 25
0.43×
0.59×
Q3 25
0.20×
0.53×
Q2 25
0.20×
0.56×
Q1 25
0.22×
0.56×
Q4 24
0.28×
0.56×
Q3 24
0.32×
0.52×
Q2 24
0.28×
0.58×
Q1 24
0.29×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
FNF
FNF
Operating Cash FlowLast quarter
$183.7M
$1.5B
Free Cash FlowOCF − Capex
$96.9M
FCF MarginFCF / Revenue
10.1%
Capex IntensityCapex / Revenue
9.0%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
FNF
FNF
Q4 25
$183.7M
$1.5B
Q3 25
$177.6M
$1.3B
Q2 25
$126.0M
$1.9B
Q1 25
$82.7M
$1.1B
Q4 24
$178.2M
$1.5B
Q3 24
$229.3M
$2.4B
Q2 24
$143.6M
$1.4B
Q1 24
$92.3M
$1.6B
Free Cash Flow
ATR
ATR
FNF
FNF
Q4 25
$96.9M
Q3 25
$114.3M
Q2 25
$62.5M
Q1 25
$25.9M
Q4 24
$112.2M
Q3 24
$162.7M
Q2 24
$75.4M
Q1 24
$16.7M
FCF Margin
ATR
ATR
FNF
FNF
Q4 25
10.1%
Q3 25
11.9%
Q2 25
6.5%
Q1 25
2.9%
Q4 24
13.2%
Q3 24
17.9%
Q2 24
8.3%
Q1 24
1.8%
Capex Intensity
ATR
ATR
FNF
FNF
Q4 25
9.0%
Q3 25
6.6%
Q2 25
6.6%
Q1 25
6.4%
Q4 24
7.8%
Q3 24
7.3%
Q2 24
7.5%
Q1 24
8.3%
Cash Conversion
ATR
ATR
FNF
FNF
Q4 25
2.47×
Q3 25
1.39×
3.66×
Q2 25
1.13×
6.82×
Q1 25
1.05×
13.43×
Q4 24
1.77×
3.32×
Q3 24
2.29×
8.89×
Q2 24
1.59×
4.45×
Q1 24
1.11×
6.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

FNF
FNF

Escrow Fees$241.0M44%
Other Title Related Fees And Income$182.0M33%
Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees$87.0M16%
Insurance Contracts Home Warranty$31.0M6%

Related Comparisons